CVS Health (NYSE:CVS) Shares Unloaded Rep. Jefferson Shreve

Representative Jefferson Shreve (R-Indiana) recently sold shares of CVS Health Corporation (NYSE:CVS). In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in CVS Health stock on May 12th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Hubbell (NYSE:HUBB) on 5/12/2025.
• Sold $50,001 – $100,000 in shares of Trane Technologies (NYSE:TT) on 5/12/2025.
• Sold $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 5/12/2025.
• Sold $50,001 – $100,000 in shares of NiSource (NYSE:NI) on 5/12/2025.
• Sold $50,001 – $100,000 in shares of Johnson & Johnson (NYSE:JNJ) on 5/12/2025.
• Sold $15,001 – $50,000 in shares of AppLovin (NASDAQ:APP) on 5/12/2025.
• Sold $15,001 – $50,000 in shares of Fiserv (NYSE:FI) on 5/12/2025.
• Sold $15,001 – $50,000 in shares of CNO Financial Group (NYSE:CNO) on 5/12/2025.
• Sold $50,001 – $100,000 in shares of Cboe Global Markets (NASDAQ:CBOE) on 5/12/2025.
• Sold $15,001 – $50,000 in shares of Lam Research (NASDAQ:LRCX) on 5/12/2025.

CVS Health Trading Up 0.7%

Shares of CVS Health stock opened at $62.52 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.63 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $64.56 and a 200 day simple moving average of $63.85. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51. The company has a market capitalization of $79.09 billion, a P/E ratio of 17.46, a price-to-earnings-growth ratio of 0.89 and a beta of 0.57.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter in the prior year, the business posted $1.83 EPS. The business’s revenue was up 8.4% compared to the same quarter last year. On average, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.3%. CVS Health’s dividend payout ratio is 74.30%.

Analyst Upgrades and Downgrades

Several research firms have commented on CVS. Jefferies Financial Group lifted their target price on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, June 30th. Wells Fargo & Company reiterated an “overweight” rating and set a $84.00 price target (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Morgan Stanley boosted their price objective on CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research report on Friday. Robert W. Baird raised their target price on CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research report on Tuesday, April 15th. Finally, Barclays boosted their price target on shares of CVS Health from $79.00 to $80.00 and gave the stock an “overweight” rating in a report on Friday. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.11.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone purchased 1,570 shares of the firm’s stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 1.22% of the company’s stock.

Institutional Investors Weigh In On CVS Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Avion Wealth raised its stake in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Hopwood Financial Services Inc. purchased a new position in CVS Health during the 4th quarter valued at about $29,000. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health during the second quarter valued at about $30,000. Bell Investment Advisors Inc lifted its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares in the last quarter. Finally, McIlrath & Eck LLC lifted its holdings in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 174 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.